These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 12656640)

  • 21. Haemoglobin, blood volume, cardiac function, and aerobic power.
    Gledhill N; Warburton D; Jamnik V
    Can J Appl Physiol; 1999 Feb; 24(1):54-65. PubMed ID: 9916181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythropoietin and analogs.
    Reichel C; Gmeiner G
    Handb Exp Pharmacol; 2010; (195):251-94. PubMed ID: 20020369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood doping and its detection.
    Jelkmann W; Lundby C
    Blood; 2011 Sep; 118(9):2395-404. PubMed ID: 21652677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood transfusions in athletes. Old dogmas, new tricks.
    Lippi G; Banfi G
    Clin Chem Lab Med; 2006; 44(12):1395-402. PubMed ID: 17163813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of darbepoetin alfa in human plasma by liquid chromatography coupled to mass spectrometry for doping control.
    Guan F; Uboh CE; Soma LR; Birksz E; Chen J
    Int J Sports Med; 2009 Feb; 30(2):80-6. PubMed ID: 19177313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring recombinant human erythropoietin abuse among athletes.
    Citartan M; Gopinath SCB; Chen Y; Lakshmipriya T; Tang TH
    Biosens Bioelectron; 2015 Jan; 63():86-98. PubMed ID: 25058943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of recombinant human EPO variants in greyhound plasma and urine by ELISA, LC-MS/MS and western blotting: a comparative study.
    Timms M; Steel R; Vine J
    Drug Test Anal; 2016 Feb; 8(2):164-76. PubMed ID: 26290355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VO2MAX, blood doping, and erythropoietin.
    Joyner MJ
    Br J Sports Med; 2003 Jun; 37(3):190-1. PubMed ID: 12782539
    [No Abstract]   [Full Text] [Related]  

  • 29. Blood manipulation: current challenges from an anti-doping perspective.
    Mørkeberg J
    Hematology Am Soc Hematol Educ Program; 2013; 2013():627-31. PubMed ID: 24319242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood boosting and sport.
    Ekblom BT
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Mar; 14(1):89-98. PubMed ID: 10932813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemoglobin in exercise adaptation.
    Burge CM
    Exerc Sport Sci Rev; 2010 Apr; 38(2):41. PubMed ID: 20335734
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessment of total haemoglobin mass: can it detect erythropoietin-induced blood manipulations?
    Lundby C; Robach P
    Eur J Appl Physiol; 2010 Jan; 108(1):197-200. PubMed ID: 19865825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic evaluation of weekly epoetin alfa versus biweekly darbepoetin alfa for chemotherapy-induced anaemia: evidence from a 16-week randomised trial.
    Reed SD; Radeva JI; Daniel DB; Mody SH; Forlenza JB; McKenzie RS; Schulman KA
    Pharmacoeconomics; 2006; 24(5):479-94. PubMed ID: 16706573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant erythropoietin misuse.
    Abellan R; Ventura R; Pichini S; Palmi I; Bellver M; Olive R; Pacifici R; Pascual JA; Zuccaro P; Segura J
    Int J Sports Med; 2007 Jan; 28(1):9-15. PubMed ID: 16804802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharma-clinics. Doping with erythropoietin or the misuse of therapeutic advances].
    Scheen AJ
    Rev Med Liege; 1998 Aug; 53(8):499-502. PubMed ID: 9810213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sports haematology.
    Shaskey DJ; Green GA
    Sports Med; 2000 Jan; 29(1):27-38. PubMed ID: 10688281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guidelines and recommendations for the management of anaemia in patients with lymphoid malignancies.
    Henry DH
    Drugs; 2007; 67(2):175-94. PubMed ID: 17284083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxygen delivery enhancers: past, present, and future.
    Borrione P; Mastrone A; Salvo RA; Spaccamiglio A; Grasso L; Angeli A
    J Endocrinol Invest; 2008 Feb; 31(2):185-92. PubMed ID: 18362513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screen and confirmation of PEG-epoetin β in equine plasma.
    Chang Y; Maylin GM; Matsumoto G; Neades SM; Catlin DH
    Drug Test Anal; 2011 Jan; 3(1):68-73. PubMed ID: 21254454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood cells RNA biomarkers as a first long-term detection strategy for EPO abuse in horseracing.
    Bailly-Chouriberry L; Noguier F; Manchon L; Piquemal D; Garcia P; Popot MA; Bonnaire Y
    Drug Test Anal; 2010 Jul; 2(7):339-45. PubMed ID: 20687115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.